TERREMOTO Trademark

Trademark Overview

On Monday, September 13, 2021, a trademark application was filed for TERREMOTO with the United States Patent and Trademark Office. The USPTO has given the TERREMOTO trademark a serial number of 97024969. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Monday, February 23, 2026. This trademark is owned by Seismic Medicines, Inc.. The TERREMOTO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Drug development services; scientific, medical, biomedical, and pharmaceutical research and development services; scientific and medical testing services in the field of pharmaceuticals; research, development, and consulting services in the field of pharmaceuticals; medical research; clinical research and development services in the field of pharmaceuticals; medical and scientific research, namely, conducting and evaluating clinical trials for others; providing information about medical and scientific research; providing scientific information in the fields of medicine and pharmaceuticals
terremoto

General Information

Serial Number97024969
Word MarkTERREMOTO
Filing DateMonday, September 13, 2021
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateMonday, February 23, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 20, 2022

Trademark Statements

Pseudo MarkTERRE MOTO
Translation of Words in MarkThe English translation of "TERREMOTO" in the mark is "earthquake".
Goods and ServicesDrug development services; scientific, medical, biomedical, and pharmaceutical research and development services; scientific and medical testing services in the field of pharmaceuticals; research, development, and consulting services in the field of pharmaceuticals; medical research; clinical research and development services in the field of pharmaceuticals; medical and scientific research, namely, conducting and evaluating clinical trials for others; providing information about medical and scientific research; providing scientific information in the fields of medicine and pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 20, 2021
Primary Code042
First Use Anywhere DateFriday, November 19, 2021
First Use In Commerce DateFriday, November 19, 2021

Trademark Owner History

Party NameTERREMOTO BIOSCIENCES, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
US
Party NameTERREMOTO BIOSCIENCES, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94158
US
Party NameTERREMOTO BIOSCIENCES, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94158
US
Party NameSeismic Medicines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025
US

Trademark Events

Event DateEvent Description
Thursday, September 16, 2021NEW APPLICATION ENTERED
Wednesday, October 20, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 25, 2022ASSIGNED TO EXAMINER
Tuesday, April 5, 2022NON-FINAL ACTION WRITTEN
Tuesday, April 5, 2022NON-FINAL ACTION E-MAILED
Tuesday, April 5, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 23, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, October 5, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 5, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 6, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 20, 2022PUBLISHED FOR OPPOSITION
Tuesday, December 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 25, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, February 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 11, 2023SOU TEAS EXTENSION RECEIVED
Friday, August 11, 2023SOU EXTENSION 1 FILED
Friday, August 11, 2023SOU EXTENSION 1 GRANTED
Tuesday, August 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 13, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 13, 2024SOU EXTENSION 2 FILED
Tuesday, February 13, 2024SOU EXTENSION 2 GRANTED
Wednesday, February 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 13, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 13, 2024SOU EXTENSION 3 FILED
Tuesday, August 13, 2024SOU EXTENSION 3 GRANTED
Tuesday, August 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 6, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 6, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 6, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 27, 2025SOU TEAS EXTENSION RECEIVED
Monday, January 27, 2025SOU EXTENSION 4 FILED
Monday, January 27, 2025SOU EXTENSION 4 GRANTED
Tuesday, March 4, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 7, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, December 23, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 6, 2025SOU EXTENSION 5 FILED
Tuesday, December 30, 2025SOU EXTENSION 5 GRANTED
Wednesday, December 31, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 9, 2026TEAS STATEMENT OF USE RECEIVED
Monday, February 9, 2026USE AMENDMENT FILED
Wednesday, February 11, 2026STATEMENT OF USE PROCESSING COMPLETE
Monday, February 23, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, February 23, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

terremoto research scientific medical services development pharmaceuticals field clinical information providing